Form 3 Filing for James A. Schoeneck

This filing reports on derivative holdings for James A. Schoeneck, a director at Connect Biopharma Holdings Ltd. The report details two stock options: one with an exercise price of $2.38 and an expiration date of July 22, 2035, for 120,000 ordinary shares, subject to vesting over three years. The second stock option has an exercise price of $2.50 and an expiration date of March 2, 2036, for 60,000 ordinary shares, fully vesting on March 2, 2027. The filing also includes a power of attorney document authorizing specific individuals to act on behalf of James A. Schoeneck for SEC filings related to Connect Biopharma Holdings Ltd. securities.